Tech Company Financing Transactions
Confluence Life Sciences Funding Round
Confluence Life Sciences, based in St. Louis, secured $500 thousand in funding from Mercury Fund.
Transaction Overview
Company Name
Announced On
12/31/2013
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Mercury Fund (Daniel Watkins)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
4320 Forest Park Avenue
St. Louis, MO 63108
USA
St. Louis, MO 63108
USA
Phone
Email Address
Overview
Confluence Life Sciences is focused on rational drug designs to develop novel kinase inhibitors for use in human and animal healthcare.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Walter Smith
Chief Scientific Officer
Joseph Monahan
Controller
Jennifer Bohnert
Browse more venture capital transactions:
Prev: 12/31/2013: SteadyServ Technologies venture capital transaction
Next: 12/31/2013: Tigo Energy venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs